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Background: Chronickidneydiseaseand its concomitant sequelae
represent a major public health problem. Recent data suggest peri-
odontal infection contributes to chronic kidney disease.
Methods: This United States population–based study of 4,053
adults ‡40 years of age investigated the association between chronic
kidney disease and clinical measures and serologic markers of peri-
odontal infection. Chronic kidney disease was defined as moderate-
to-severe reduction of kidney function with glomerular filtration rate
of 15 to 59 ml/minute/1.73 m2 based on stages 3 and 4 of the Kidney
Disease Outcome Quality Initiative. Chronic oral inflammatory bur-
den was measured as 1) clinical periodontal infection categorized
as no periodontal disease, periodontal disease (at least one tooth
with ‡4 mm loss of attachment and bleeding on probing as an indica-
tor of inflammation), or edentulism and 2) serum immunoglobulin G
antibody response to Aggregatibacter actinomycetemcomitans (pre-
viously Actinobacillus actinomycetemcomitans) and Porphyromo-
nas gingivalis. Multiple logistic regression modeling quantified the
association between chronic kidney disease and chronic inflamma-
tory burden and other risk factors.
Results: Nine percent of the study population had chronic kidney
disease, 22% had high A. actinomycetemcomitans antibody titer,
24% had high P. gingivalis antibody titer, 9% had periodontal disease,
and 17% were edentulous. After simultaneously adjusting for recog-
nized risk factors, adults with a high A. actinomycetemcomitans titer
were less likely to have chronic kidney disease (adjusted odds ratio
[ORAdj] = 0.67; 95% confidence interval [CI]: 0.46 to 0.98), and adults
with edentulism were more likely to have chronic kidney disease
(ORAdj = 1.64; 95% CI: 1.11 to 2.44).
Conclusion: These results support considering edentulism and
low serum titer to A. actinomycetemcomitans as risk indicators for
chronic kidney disease. J Periodontol 2008;79:1670-1678.
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C
hronic kidney disease and its
concomitant serious seque-
lae (i.e., end-stage kidney
failure, cardiovascular disease, and
premature death) represent a major
public health problem in the United
States.1 During 1999 to 2000, an
estimated 7 million adults in the
United States had chronic kidney
disease on the basis of a moderate-
to-severe reduction of kidney func-
tion (glomerular filtration rate [GFR]
between 15 and 59 ml/minute/1.73
m2).2 This level of decreased kidney
functioncorresponds tostages 3and
4 of the Kidney Disease Outcome
Quality Initiative.3
Chronic inflammatory burden has
been suggested as a risk factor for
chronic kidney disease4-7 and ather-
osclerotic cardiovascular disease.5
Recent data suggest that high peri-
odontal pathogen antibody titers,8
periodontal disease incorporating
bleeding as an indicator of active in-
flammation,9 and markers of chronic
inflammatory burden contribute to
chronic kidney disease.6 Systemic
dissemination of bacterial patho-
gens, antigens, endotoxins, and in-
flammatory cytokines is related to
the chronic inflammatory burden
of periodontal disease.10,11
As a source of systemic inflam-
matory burden, it is biologically
plausible to consider periodontal
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disease as a putative risk factor for chronic kidney dis-
ease. In a recent report12 from a nationally represen-
tative population sample, high antibody titers to the
periodontal pathogen Porphyromonas gingivalis
and clinical periodontal disease were independently
associated with high levels of the inflammatory
marker C-reactive protein but high antibody titers to
Aggregatibacter actinomycetemcomitans (previously
Actinobacillus actinomycetemcomitans) were not.
The purpose of this study was to evaluate and
quantify the independent association between clinical
and serologic markers of periodontal infection and
chronic kidney disease in a representative sample
of the United States population. We also considered
C-reactive protein as an additional factor that may
contribute to the chronic inflammatory burden.
MATERIALS AND METHODS
Study Population
This cross-sectional study was approved by the Case
Western Reserve University institutional review board.
The Third National Health and Nutrition Examination
Survey (NHANES III), conducted between 1988 and
1994, is a complex, multistage, stratified, clustered
sample representative of the civilian, non-institution-
alized United States population. NHANES III included
questionnaire, laboratory assays, and clinical exami-
nation measures of health outcomes and explanatory
variables.13 We identified 4,053 adults ‡40 years of
age with a mean age of 57.4 years, representing
42.5 million Americans, with information on kidney
function and assessments of serum immunoglobulin
G antibody against A. actinomycetemcomitans and
P. gingivalis. Similar to a previous analysis of this
dataset,12 we excluded those among the upper and
lower 2% of reported antibody titers to minimize the
effects of extreme values.
Description of Main Outcome
The main outcome was chronic kidney disease with
moderate-to-severe reduction of kidney function de-
fined by a GFR 15 to 59 ml/minute/1.73 m2 based
on stages 3 and 4 of the Kidney Disease Outcome
Quality Initiative.3 The combination of moderately
and severely decreased kidney function provides a
single, more precise estimate of decreased kidney
function.2 GFR was estimated using the simplified
Modification of Diet in Renal Disease Study equation:
GFR = 186.3 · (serum creatinine in mg/dl)-1.154 ·
age-0.203 · (0.742 if female) · (1.21 if black). The se-
rum creatinine value was calibrated by subtracting
0.23 to align the NHANES measures with creatinine
assays in the aforementioned equation.14
Description of Risk Factors and Risk Indicators
The main exposure or risk indicator for this analysis
was chronic oral inflammatory burden measured as
dentate status and clinical and serologic markers of
periodontal infection. Clinical periodontal infection
was defined using three categories: no periodontal
disease, periodontal disease, or edentulous status.
Periodontal disease was defined as having one or
more teeth with loss of attachment ‡4 mm and bleed-
ing on probing (with bleeding on probing as an indica-
tor of active inflammation).15 Edentulous was defined
as having lost all natural teeth. The rationale for in-
cluding edentulism in the analysis was based on the
observation that periodontal disease is the major
cause of edentulism among 40- to 69-year-olds, with
60.5% of teeth extracted due to periodontal disease;16
tooth loss was a marker of past periodontal disease
among adults ‡55 years of age;17 and non-surgical
periodontal therapy was associated with a reduction
in the rate of tooth loss.18
Serologic markers of periodontal infection were
measured as periodontal pathogen antibody levels,
categorized with the upper 20% titer levels identifying
high titers and the lower 80% titers identifying low
titers. The following four combinations of A. actino-
mycetemcomitans and P. gingivalis antibody titers
were used: high A. actinomycetemcomitans and high
P. gingivalis titer, high A. actinomycetemcomitans
and low P. gingivalis titer, low A. actinomycetemcomi-
tans and high P. gingivalis titer, and low A. actinomy-
cetemcomitans and high P. gingivalis titer. The
detection of antibodies to A. actinomycetemcomitans
and P. gingivalis was carried out by enzyme-linked im-
munosorbent assay as described in the NHANES III
Periodontal Pathogen Antibody Documentation.13
Other recognized risk factors for chronic kid-
ney disease included age (40- to 59-year-olds ver-
sus ‡60-year-olds), race/ethnicity (non-Hispanic
white, non-Hispanic black, and Mexican-Americans),
lower income (<$20,000 annual household income),
education (highschoolgraduate), and systemichyper-
tension (systolic pressure >140 mm Hg or diastolic
pressure >90 mm Hg, or being told on two or more dif-
ferentvisits thatonehadhypertension).Blood pressure
was measured according to the standardized proce-
dures recommended by the American Heart Associ-
ation19 to reduce misclassification bias. Other risk
factors included self-reported smoking status (cur-
rent, former, or never-smoker), macroalbuminuria
(urinary albumin-to-creatinine excretion ratio ‡300
mg/g),2,3 high C-reactive protein (as a marker for sys-
temic inflammatory burden, >3.0 mg/dl), high total
serum cholesterol (‡240 mg/dl), low serum high-
density lipoprotein cholesterol (£35 mg/dl), high se-
rum low-density lipoprotein cholesterol (‡160 mg/
dl), obesity (body mass index ‡30 kg/m2), and dia-
betes mellitus status (no diabetes, diabetes with
good control [<7% glycated hemoglobin], and diabe-
tes with poorer control [‡7% glycated hemoglobin]).
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Diabetes mellitus was defined as fasting plasma
glucose ‡126 mg/dl or ‡200 mg/dl after an oral glu-
cose tolerance test,20 or self-reported, physician-
diagnosed diabetes.
Statistical Analyses
Tests of the hypotheses that clinical and serologic
markers of periodontal infection and other risk factors
were associated with chronic kidney disease were ex-
amined using univariable analysis and multivariable
logistic regression modeling. For the latter, a forward
stepwise regression approach was performed to si-
multaneously take into account the statistically signif-
icant risk factors determined by univariable analyses,
with statistical significance reported as 95% confi-
dence interval (CI) not including the value of 1.0.
The independent association was quantified using
the adjusted odds ratio (ORAdj) for the association be-
tween chronic kidney disease and the following risk
factors/risk markers: measures of socioeconomic
status (i.e., age, race/ethnicity, gender, income,
and education), health status, health behavior, bio-
markers, and health care use. Analyses were con-
ducted using software packages¶# to account for




Table 1 presents important characteristics of the
study population and their unadjusted association
with chronic kidney disease. The prevalence of
chronic kidney disease was 9% in this United States
population–based study. The following health condi-
tions were common and were associated with chronic
kidney disease in univariable analyses: 17% were
edentulous (ORCrude = 3.54; 95% CI: 2.54 to 4.93),
11% had diabetes mellitus with better glycemic con-
trol (ORCrude = 1.58; 95% CI: 1.08 to 2.30), 7% had di-
abetes mellitus withpoorer glycemiccontrol (ORCrude =
1.89; 95% CI: 1.20 to 2.98), 41% had hypertension
(ORCrude = 4.29; 95% CI: 3.17 to 5.81), 26% had high
cholesterol (ORCrude =1.82;95%CI:1.35 to2.47),15%
had low high-density lipoprotein (ORCrude = 1.67; 95%
CI: 1.07 to 2.60), and 21% had high low-density lipo-
protein (ORCrude = 1.61; 95% CI: 1.05 to 2.47). In ad-
dition, 9% had periodontal disease (ORCrude = 1.26;
95% CI: 0.78 to 2.03) and 29% were obese (ORCrude =
1.08; 95% CI: 0.73 to 1.59); neither of these was sig-
nificantly associated with chronic kidney disease in
univariable analysis. The following health conditions
were less common and were associated with chronic
kidney disease in univariable analysis: 2% had macro-
albuminuria (ORCrude = 8.47; 95% CI: 5.13 to 14.00),
and 1% had high C-reactive protein (ORCrude = 2.60;
95% CI: 1.11 to 6.07).
Multivariable Logistic Regression Models
Table 2 presents the most parsimonious models of
clinical and serologic markers of periodontal infection
and other risk factors for chronic kidney disease, si-
multaneously adjusting for the listed risk factors.
The first model with clinical periodontal infection (col-
umn 2) indicates adults who were edentulous (ORAdj =
1.61; 95% CI: 1.09 to 2.37), older (ORAdj = 8.60; 95%
CI: 5.15 to 14.35), non-Hispanic white (ORAdj = 2.68;
95% CI: 1.40 to 5.14), female (ORAdj = 1.91; 95% CI:
1.20 to 3.04), had an annual physician visit (ORAdj =
2.32; 95% CI: 1.12 to 4.79), had low high-density lipo-
protein (ORAdj = 2.04; 95% CI: 1.22 to 3.41), had hy-
pertension (ORAdj = 1.86; 95% CI: 1.35 to 2.56), did
not graduate from high school (ORAdj = 1.37; 95%
CI: 1.06 to 1.76), were former smokers (ORAdj =
1.38; 95% CI: 1.05 to 1.81), or who had macro-
albuminuria (ORAdj = 4.07; 95% CI: 2.51 to 6.59) were
more likely to have chronic kidney disease,after simul-
taneously adjusting for these factors.
In the next model (Table 2, column 3) containing
clinical periodontal infection and A. actinomycetem-
comitans antibody titer, edentulous adults remained
more likely to have chronic kidney disease (ORAdj =
1.58; 95% CI: 1.07 to 2.34), and adults with high
A. actinomycetemcomitans antibody titer were less
likely to have chronic kidney disease (ORAdj = 0.67;
95% CI: 0.46 to 0.98). In the last model (Table 2, col-
umn 4) containing the combination of A. actinomyce-
temcomitans and P. gingivalis antibody titers and
clinical periodontal infection status, adults with high
A. actinomycetemcomitans titer and low P. gingivalis
titer were less likely to have chronic kidney disease
(ORAdj = 0.61; 95% CI: 0.39 to 0.97) than those with low
A. actinomycetemcomitans titer and low P. gingivalis
titer, after simultaneously adjusting for other factors.
In all three models, there was little change in the es-
timated adjusted OR for the nine other factors inde-
pendently associated with chronic kidney disease:
age, race/ethnicity, gender, smoking status, macroal-
buminuria, high-density lipoprotein, hypertension,
education, and health care use (i.e., annual physician
visit). The following risk factors were not included in
the final models because they were not statistically
significant: lower income, diabetes status, obesity, high
C-reactive protein, low-density lipoprotein choles-
terol, and being hospitalized in the past year.
DISCUSSION
We investigated the independent association between
prevalent chronic kidney disease and chronic oral and
systemic inflammatory burden measured as 1) clini-
cal periodontal infection incorporating the current
¶ SAS-Callable SUDAAN version 9.0.1, Research Triangle Institute,
Research Triangle Park, NC.
# SAS Systems for Windows, version 9.1, SAS Institute, Cary, NC.
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Table 1.
Descriptive Summary and Associations Between Risk Factors and Chronic Kidney
Disease in United States Adults ‡40 Years of Age
Risk Factors*
No Chronic Kidney Disease
(n = 3,632; 91.5%)
Chronic Kidney Disease
(n = 421; 8.5%) ORCrude (95% CI)
Socioeconomic
Age (years)
40 to 59 (n = 1,866; 59.1%) 98.2% 1.8% 1.00
‡60 (n = 2,187; 40.9%) 81.8% 18.2% 12.05 (7.17 to 20.27)†
Race/ethnicity
Non-Hispanic white (n = 2,029; 86.9%) 91.0% 9.0% 3.18 (1.79 to 5.63)†
Non-Hispanic black (n = 968; 9.4%) 94.3% 5.7% 1.92 (0.99 to 3.75)
Mexican American (n = 867; 3.6%) 97.0% 3.0% 1.00
Gender
Female (n = 2,246; 54.2%) 90.2% 9.8% 1.45 (1.01 to 2.09)†
Male (n = 1,807; 45.8%) 93.0% 7.0% 1.00
Lower income
Yes (n = 1,882; 30.3%) 85.5% 14.5% 2.75 (1.94 to 3.89)†
No (n = 2,063; 69.7%) 94.2% 5.8% 1.00
High school graduate
Yes (n = 2,238; 73.2%) 93.6% 6.4% 1.00
No (n = 1,786; 26.8%) 85.6% 14.4% 2.48 (1.89 to 3.25)†
Health status and health behavior
Periodontal antibodies
Aa
High Aa (n = 1,084; 22.0%) 94.0% 6.0% 0.63 (0.43 to 0.92)†
Low Aa (n = 2,969; 78.0%) 90.7% 9.3% 1.00
Pg
High Pg (n = 1,375; 24.4%) 91.5% 8.5% 0.99 (0.68 to 1.43)
Low Pg (n = 2,678; 75.6%) 91.4% 8.6% 1.00
Combination of Aa and Pg
High Aa and high Pg (n = 533; 8.1%) 93.2% 6.8% 0.72 (0.43 to 1.21)
High Aa and low Pg (n = 551; 13.9%) 94.5% 5.5% 0.58 (0.34 to 0.97)†
Low Aa and high Pg (n = 842; 16.3%) 90.7% 9.3% 1.00 (0.64 to 1.57)
Low Aa and low Pg (n = 2,127; 61.7%) 90.7% 9.3% 1.00
Periodontal status
Edentulous (n = 803; 17.1%) 81.0% 19.0% 3.54 (2.54 to 4.93)†
Periodontal disease (n = 526; 8.5%) 92.3% 7.7% 1.26 (0.78 to 2.03)
No periodontal disease (n = 2,724; 74.4%) 93.8% 6.2% 1.00
Diabetes status
Poor control (n = 396; 6.8%) 86.4% 13.6% 1.89 (1.20 to 2.98)†
Good control (n = 520; 10.9%) 88.4% 11.6% 1.58 (1.08 to 2.30)†
No diabetes (n = 3,137; 82.3%) 92.3% 7.7% 1.00
Hypertension
Yes (n = 2,003; 40.6%) 84.8% 15.2% 4.29 (3.17 to 5.81)†
No (n = 2,047; 59.4%) 96.0% 4.0% 1.00
Macroalbuminuria
Yes (n = 141; 1.7%) 57.7% 42.3% 8.47 (5.13 to 14.00)†
No (n = 3,912; 98.3%) 92.0% 8.0% 1.00
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presence of periodontal inflammation in the clinical
measure by requiring bleeding on probing on the
same tooth with attachment loss;15 2) systemic anti-
body response to periodontal pathogens;8,10-12,21-28
and 3) C-reactive protein.4,6,12 Edentulism and spe-
cific serologic markers of periodontal infection were
independent risk indicators for chronic kidney dis-
ease. High C-reactive protein was not found to be an
independent risk factor after simultaneously consider-
ing several other recognized risk markers for chronic
kidney disease, i.e., age, race/ethnicity, gender, educa-
tion, smoking status, annual physician visit, high-den-
sity lipoprotein, hypertension, and macroalbuminuria.
Our study approach contributes to previous evi-
dence by supporting the concept of the role of chronic
inflammatory burden in chronic kidney disease path-
ogenesis through the assessment of the systemic
antibody response to periodontal pathogens and by
including edentulous adults who represented 17% of
the United States population ‡40 years of age. Our
population-based study is consistent with previous
studies1-3,9,29-32 of high-risk chronic kidney disease
subgroups and provides a basis to consider extending
the list of risk factors/indicators to include clinical and
serologic markers of periodontal infection in a multi-
variable model of risk for chronic kidney disease.
Based on the current evidence that chronic infection
bydentalplaquebacteria isetiologicforperiodontaldis-
ease, it is biologically plausible to hypothesize that the
systemic inflammatory burden related to periodontal
disease is associated with chronic kidney disease.
The response to periodontal pathogens leads to a local,
Table 1. (continued)
Descriptive Summary and Associations Between Risk Factors and Chronic Kidney
Disease in United States Adults ‡40 Years of Age
Risk Factors*
No Chronic Kidney Disease
(n = 3,632; 91.5%)
Chronic Kidney Disease
(n = 421; 8.5%) ORCrude (95% CI)
Obesity
Yes (n = 1,220; 28.8%) 91.0% 9.0% 1.08 (0.73 to 1.59)
No (n = 2,827; 71.2%) 91.6% 8.4% 1.00
High C-reactive protein
Yes (n = 78; 1.3%) 80.8% 19.2% 2.60 (1.11 to 6.07)†
No (n = 3,973; 98.7%) 91.6% 8.4% 1.00
High cholesterol
Yes (n = 1,095; 26.3%) 87.6% 12.4% 1.82 (1.35 to 2.47)†
No (n = 2,943; 73.7%) 92.8% 7.2% 1.00
Low high-density lipoprotein
Yes (n = 579; 14.7%) 87.5% 12.5% 1.67 (1.07 to 2.60)†
No (n = 3,423; 85.3%) 92.1% 7.9% 1.00
High low-density lipoprotein
Yes (n = 392, 20.9%) 89.3% 10.7% 1.61 (1.05 to 2.47)†
No (n = 1,322, 79.1%) 93.0% 7.0% 1.00
Smoking status
Never (n = 1,899; 44.0%) 91.6% 8.4% 1.92 (1.21 to 3.05)†
Former (n = 1,265; 33.9%) 88.8% 11.2% 2.64 (1.64 to 4.25)†
Current (n = 889; 22.1%) 95.4% 4.6% 1.00
Hospitalized in past year
Yes (n = 662; 13.6%) 86.4% 13.6% 1.89 (1.33 to 2.70)†
No (n = 3,378; 86.4%) 92.3% 7.7% 1.00
Annual physician visit
Yes (n = 3,393; 82.9%) 90.6% 9.4% 3.02 (1.50 to 6.08)†
No (n = 636; 17.1%) 96.7% 3.3% 1.00
Unweighted number with weighted percent.
Inclusion criteria: periodontal pathogen titers and serum creatinine data.
ORCrude = unadjusted OR for the association between chronic kidney disease and the listed risk factors; Aa = A. actinomycetemcomitans; Pg = P. gingivalis.
* Not all participants answered all questions or had all serum assays performed.
† P <0.05.
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Table 2.
Final Logistic Regression Models of Association Between Clinical and Serologic Markers of





Model With Clinical Periodontal
Infection and Aa Antibody Titer
ORAdj (95% CI)
Model With Clinical Periodontal




High Aa 0.67 (0.46 to 0.98)*
Combination Aa and Pg antibody titers
High Aa and high Pg 0.89 (0.48 to 1.67)
High Aa and low Pg 0.61 (0.39 to 0.97)*
Low Aa and high Pg 1.16 (0.74 to 1.80)
Low Aa and low Pg 1.00
Periodontal clinical status
Edentulous 1.61 (1.09 to 2.37)* 1.58 (1.07 to 2.34)* 1.64 (1.11 to 2.44)*
Periodontal disease 1.20 (0.76 to 1.90) 1.23 (0.78 to 1.95) 1.20 (0.75 to 1.93)
No periodontal disease 1.00 1.00 1.00
Age (years)
‡60 8.60 (5.15 to 14.35)* 8.73 (5.28 to 14.42)* 8.68 (5.24 to 14.39)*
40 to 59 1.00 1.00 1.00
Race/ethnicity
Non-Hispanic white 2.68 (1.40 to 5.14)* 2.57 (1.34 to 4.91)* 2.70 (1.39 to 5.27)*
Non-Hispanic black 1.53 (0.73 to 3.18) 1.48 (0.71 to 3.09) 1.47 (0.70 to 3.08)
Mexican American 1.00 1.00 1.00
Gender
Female 1.91 (1.20 to 3.04)* 1.86 (1.17 to 2.97)* 1.86 (1.17 to 2.95)*
Male 1.00 1.00 1.00
High school graduate
No 1.37 (1.06 to 1.76)* 1.40 (1.08 to 1.80)* 1.39 (1.08 to 1.79)*
Yes 1.00 1.00 1.00
Smoking status
Current 0.68 (0.44 to 1.03) 0.68 (0.45 to 1.04) 0.68 (0.45 to 1.04)
Former 1.38 (1.05 to 1.81)* 1.40 (1.07 to 1.84)* 1.40 (1.07 to 1.84)*
Never 1.00 1.00 1.00
Annual physician visit
Yes 2.32 (1.12 to 4.79)* 2.33 (1.13 to 4.82)* 2.40 (1.18 to 4.86)*
No 1.00 1.00 1.00
Low high-density lipoprotein
Yes 2.04 (1.22 to 3.41)* 2.01 (1.20 to 3.38)* 2.00 (1.19 to 3.37)*
No 1.00 1.00 1.00
Hypertension
Yes 1.86 (1.35 to 2.56)* 1.87 (1.36 to 2.56)* 1.86 (1.36 to 2.55)*
No 1.00 1.00 1.00
Macroalbuminuria
Yes 4.07 (2.51 to 6.59)* 4.02 (2.42 to 6.69)* 4.03 (2.40 to 6.74)*
No 1.00 1.00 1.00
ORAdj = OR for the association between chronic kidney disease, simultaneously taking into account all of the risk factors included in the model; Aa =
A. actinomycetemcomitans; Pg = P. gingivalis.
The following risk factors were not included in the final model because they were not statistically significant: lower income, diabetes status, obesity, high
C-reactive protein, low-density lipoprotein cholesterol, and hospitalized in the past year.
* P <0.05.
J Periodontol • September 2008 Fisher, Taylor, Papapanou, Rahman, Debanne
1675
tissue-destructive immunoinflammatory response that
is believed to create a chronic systemic inflammatory
burdensecondarytothesystemicdisseminationofperi-
odontal pathogenic bacteria, their products (e.g., lipo-
polysaccharides), and locally produced inflammatory
mediators including cytokines, chemokines, and in-
flammatory peptides.25,26 This systemic inflammatory
burden has been suggested to contribute to endothe-
lial injury and atherogenesis.22,33 An increasing body
of epidemiologic evidence supports a significant asso-
ciation between periodontal infections (i.e., systemic
antibody titers to periodontal pathogens) and cardio-
vascular diseases.21,24,27 Additionally, clinical studies
involving treatment of chronic periodontitis reported
an improvement of secondary endpoints considered
important in cardiovascular disease risk,26 including
a recently reported randomized clinical trial22 demon-
strating a significant improvement in endothelial func-
tion following periodontal treatment.
In our study of a representative sample of the
United States population, clinical periodontal status
and serologic markers of periodontal infection were
independently associated with chronic kidney dis-
ease. First, we modeled the association between
chronic kidney disease and clinical periodontal infec-
tion and found a significant association with dentate
status (i.e., edentulism) but not with periodontal dis-
ease (this may be an underestimate of the true asso-
ciation; see later discussion). After adding serologic
markers of periodontal infection to the model, A. ac-
tinomycetemcomitans titer remained significantly
associated with chronic kidney disease when the
combination of A. actinomycetemcomitans and P.
gingivalis titers was evaluated, suggesting that a
composite systemic antibody response to the total
periodontal pathogen burden may be important in this
context. In our analysis, individuals with a combina-
tion of high A. actinomycetemcomitans titer and low
P. gingivalis titer remained significantly less likely to
have chronic kidney disease than those with low A. ac-
tinomycetemcomitans titer and low P. gingivalis titer.
Our finding is somewhat contrary to the recent report8
from the Atherosclerosis Risk in Communities (ARIC)
study that reported high antibody titers to P. gingivalis
were associated with chronic kidney disease.
A limitation of the dental component of the ARIC
study and our study is the cross-sectional study de-
sign, which precludes assessment of the temporal as-
sociation between the systemic antibody response to
periodontal pathogens and chronic kidney disease. In
addition, it is not feasible to determine whether high
levels of antibody titers to periodontal pathogens sig-
nify a new occurrence of infection or a current chronic
or previously resolved bacterial infection. An earlier
study28 suggested systemic antibody titers might
reflect a history of periodontal infection. This may
explain the association between edentulism and
chronic kidney disease; if some of the teeth of eden-
tulous adults had long-term periodontal disease (all
of the teeth need not have been extracted as a result
of periodontal disease), the resultant chronic inflam-
matory burden may have played a role in the kidney
damage.
Another limitation of our study is the probable un-
derestimation of clinical periodontal disease related to
the NHANES study design. Periodontal data were de-
rived from random half-mouth examinations mea-
suring two sites per tooth, which underestimates the
prevalence of periodontal disease.34 This under-
estimation of periodontal disease in individuals with
and without chronic kidney disease results in an un-
derreporting of the true association between chronic
kidney disease and periodontal disease.35 Although
we did not find a significant association between
chronic kidney disease and clinical periodontal dis-
ease, periodontal pathogen antibody titer levels were
associated with chronic kidney disease, similar to
those reported in a study of heart disease. Our finding
is consistent with Beck et al.,10 who reported that clin-
ical signs of periodontal disease were not associated
with heart disease, but antibody titer levels to Prevo-
tella nigrescens or A. actinomycetemcomitans were
associated with heart disease.
Our study has several strengths. First, we focused
on the simultaneous assessment of chronic inflam-
matory burden, including the systemic antibody re-
sponse to periodontal pathogens and C-reactive
protein, in addition to other risk factors for chronic
kidney disease. Second, our analysis of the combina-
tion of A. actinomycetemcomitans and P. gingivalis
titer suggests that further research is needed to inves-
tigate systemic antibody responses to clusters of
periodontal pathogens. Third, our multivariable mod-
eling approach begins to address concerns that host-
related and environmental factors, such as race/
ethnicity, age, diabetes, and smoking, may affect
serum antibody levels by simultaneously adjusting
for these factors.36 Fourth, questionnaire, examina-
tion, and laboratory data were collected in an unbi-
ased manner such that the participants were
unaware of our study on risk factors/indicators for
chronic kidney disease. Fifth, our study population in-
cluded dentate and edentulous adults, unlike studies
discussed previously, which were limited to dentate
individuals.
CONCLUSIONS
Our findings support the conclusion that edentulous
adults are more likely to have chronic kidney disease,
and those with a high level of systemic antibody re-
sponse to one of the major periodontal pathogens
(A. actinomycetemcomitans) are less likely to have
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chronic kidney disease after controlling for other risk
factors. Further research is needed to evaluate the
causal inferences regarding the role of periodontal
pathogen burden and its contribution to systemic in-
flammatory burden in longitudinal studies of chronic
kidney disease with dentate and edentulous adults.
Another potential next step is to consider periodontal
therapy as a means to contribute to reducing the
chronic inflammatory burden in multifactorial inter-
ventions that might include counseling to modify
patients’ behavior (e.g., smoking cessation counsel-
ing,37 diet modification, and exercise initiation) and
antihypertensive drug therapy3,31,38 directed toward
reducing the incidence, progression, and complica-
tions of chronic kidney disease.
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